✦ LIBER ✦

Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

✍ Scribed by Zsofia K. Stadler; Erin Salo-Mullen; Sujata M. Patil; M. Catherine Pietanza; Joseph Vijai; Emmanouil Saloustros; Nichole A. L. Hansen; Noah D. Kauff; Robert C. Kurtz; David P. Kelsen; Kenneth Offit; Mark E. Robson

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 141 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26191

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutational analyses of BRCA1 and BRCA2 i

Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer

✍ Ronit Shiri-Sverdlov; Peter Oefner; Limor Green; Ruth Gershoni Baruch; Teresa Wa 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 2 views

BRCA1 and BRCA2 mutations in Russian fam

BRCA1 and BRCA2 mutations in Russian familial breast cancer

✍ Irina V. Tereschenko; Victoria M. Basham; Bruce A.J. Ponder; Paul D.P. Pharoah 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 2 views

We have screened index cases from 25 Russian breast/ovarian cancer families for germ-line mutations in all coding exons of the BRCA1 and BRCA2 genes, using multiplex heteroduplex analysis. In addition we tested 22 patients with breast cancer diagnosed before age 40 without family history and 6 patie

A low frequency of non-founder BRCA1 mut

A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast–ovarian cancer families

✍ Catherine M. Phelan; Elaine Kwan; Elaine Jack; Song Li; Cindy Morgan; Jennifer A 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

The 185delAG and 5382insC founder mutations account for the majority of mutations identified in BRCA1 in Ashkenazi Jewish breast and breast-ovarian cancer families. Few non-founder BRCA1 mutations have been identified to date in these families. We initially screened a panel of 245 Ashkenazi Jewish b

Frequency of BRCA1 and BRCA2 germline mu

Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families

✍ Noriko Ikeda; Yasuo Miyoshi; Kohri Yoneda; Eiichi Shiba; Yoshizo Sekihara; Morit 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 2 views

Prevalence of BRCA1 and BRCA2 mutations

Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

✍ Muhammad U. Rashid; Anbreen Zaidi; Diana Torres; Faisal Sultan; Axel Benner; Bil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB 👁 2 views

## Abstract Among Asian countries, Pakistan has the highest rates of breast and ovarian cancer. To assess the contribution of the __BRCA1__ and __BRCA2__ germ line mutations to these high rates, we conducted the first study of 176 Pakistani breast and ovarian cancer patients, selected on family his

Germline mutations of BRCA1 and BRCA2 in

Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families

✍ Hio Chung Kang; Il-Jin Kim; Jae-Hyun Park; Hyuk-Jun Kwon; Yong-Jin Won; Seung Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Germline mutations in the BRCA1 and BRCA2 genes are responsible for the predisposition and development of familial breast and/or ovarian cancer. Most mutations of BRCA1 and BRCA2 associated with breast and/or ovarian cancer result in truncated proteins. To investigate the presence of BRCA1 and BRCA2